作者: Junying Yuan , Gregory D. Cuny , Alexei Degterev
DOI:
关键词:
摘要: The present invention relates to isolated deuterated compounds (e.g., described by Formula (I) and pharmaceutically acceptable salts thereof. also isotopically enriched compositions that include according features pharmaceutical these their use in therapy for treating conditions which necroptosis is likely play a substantial role, or those RIP1 and/or RIP3 protein contributing factor, (structure shown)